Facts, Views & Vision
in ObGyn

Journal of the European Society for Gynaecological Endoscopy

esge_logo

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

D. Timmerman, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.

F. Planchamp, Clinical Research Unit, Institut Bergonie, Bordeaux, France.

T. Bourne, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Department of Metabolism, Digestion and Reproduction, Queen Charlotte’s & Chelsea Hospital, Imperial College, London, UK.

C. Landolfo, Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

A. du Bois, Department of Gynaecology and Gynaecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.

L. Chiva, Department of Gynaecology and Obstetrics, University Clinic of Navarra, Madrid, Spain.

D. Cibula, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic.

N. Concin, Department of Gynaecology and Gynaecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany; Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Innsbruck, Austria.

D. Fischerova, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic.

W. Froyman, Department of Obstetrics and Gynaecology, University Hospitals KU Leuven, Leuven, Belgium

G. Gallardo, Department of Radiology, University Clinic of Navarra, Madrid, Spain.

B. Lemley, Patient Representative, President of Kræfti Underlivet (KIU), Denmark; Chair Clinical Trial Project of the European Network of Gynaecological Cancer Advocacy Groups, ENGAGe.

A. Loft, Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

L. Mereu, Department of Gynaecology and Obstetrics, Gynaecologic Oncology Unit, Santa Chiara Hospital, Trento, Italy.

P. Morice, Department of Gynaecological Surgery, Institut Gustave Roussy, Villejuif, France.

D. Querleu, Division of Gynaecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Department of Obstetrics and Gynaecologic
Oncology, University Hospital, Strasbourg, France.

C. Testa, Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Institute of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy.

I. Vergote, Department of Obstetrics and Gynaecology and Gynaecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.

V. Vandecaveye, Department of Radiology, University Hospitals Leuven, Leuven Belgium; Division of Translational MRI, Department of Imaging & Pathology KU Leuven, Leuven, Belgium.

G. Scambia, Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Institute of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy.

C. Fotopoulou, Department of Gynaecologic Oncology, Hammersmith Hospital, Imperial College, London, UK.


Published online: Jun 28 2021

https://doi.org/10.52054/FVVO.13.2.016

Abstract

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the preoperative diagnosis of ovarian tumours, including imaging techniques, biomarkers and prediction models.

ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the preoperative diagnosis of ovarian tumours and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised.

Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements.

This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the preoperative diagnosis of ovarian tumours and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.